Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Major Shareholder Sells $31,415.40 in Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) major shareholder J.H. Whitney Equity Partners V sold 5,580 shares of the stock in a transaction on Tuesday, April 1st. The shares were sold at an average price of $5.63, for a total transaction of $31,415.40. Following the completion of the sale, the insider now directly owns 1,451,598 shares in the company, valued at approximately $8,172,496.74. This represents a 0.38 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Major shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

J.H. Whitney Equity Partners V also recently made the following trade(s):

• On Monday, March 24th, J.H. Whitney Equity Partners V sold 268 shares of Aveanna Healthcare stock. The stock was sold at an average price of $5.63, for a total transaction of $1,508.84.
• On Tuesday, March 18th, J.H. Whitney Equity Partners V sold 61,564 shares of Aveanna Healthcare stock. The shares were sold at an average price of $5.51, for a total value of $339,217.64.

Aveanna Healthcare Stock Performance

Shares of NASDAQ AVAH opened at $5.03 on Friday. The stock has a 50 day moving average price of $4.78 and a 200 day moving average price of $4.96. The firm has a market capitalization of $981.32 million, a price-to-earnings ratio of -14.79 and a beta of 1.99. Aveanna Healthcare Holdings Inc. has a 52-week low of $2.11 and a 52-week high of $6.19.

Analysts Set New Price Targets

A number of brokerages recently issued reports on AVAH. UBS Group raised their price target on Aveanna Healthcare from $3.20 to $4.50 and gave the stock a “sell” rating in a research note on Friday, March 14th. Truist Financial decreased their target price on Aveanna Healthcare from $6.00 to $5.25 and set a “hold” rating for the company in a research report on Monday, January 6th.

Institutional Investors Weigh In On Aveanna Healthcare

Several hedge funds have recently made changes to their positions in the company. JPMorgan Chase & Co. raised its holdings in shares of Aveanna Healthcare by 266.4% in the third quarter. JPMorgan Chase & Co. now owns 85,714 shares of the company’s stock valued at $446,000 after acquiring an additional 62,319 shares in the last quarter. State Street Corp lifted its position in shares of Aveanna Healthcare by 0.9% in the 3rd quarter. State Street Corp now owns 1,039,920 shares of the company’s stock worth $5,408,000 after purchasing an additional 9,446 shares during the period. XTX Topco Ltd bought a new position in shares of Aveanna Healthcare during the third quarter valued at approximately $92,000. Barclays PLC increased its holdings in Aveanna Healthcare by 80.1% during the third quarter. Barclays PLC now owns 122,689 shares of the company’s stock valued at $637,000 after buying an additional 54,557 shares during the period. Finally, Rhumbline Advisers raised its stake in Aveanna Healthcare by 11.1% in the fourth quarter. Rhumbline Advisers now owns 72,663 shares of the company’s stock worth $332,000 after buying an additional 7,257 shares in the last quarter. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

Aveanna Healthcare Company Profile

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.